B Braun Medical announced that the US Food and Drug Administration (FDA) granted 510(k) clearance of its Introcan Safety 3 closed IV catheter. B Braun made the announcement during the Association for Vascular Access 2011 Annual Scientific Meeting in San Jose, California, USA, in early October.
“Recent research confirms passive safety engineered devices are most effective for needlestick injury prevention,” said Tom Sutton, vice president, Vascular Access and IV Systems at B Braun Medical. “The Introcan Safety 3 is designed to provide clinicians with not only an effective passive needlestick safety device, but also an added layer of safety and control with a bidirectional blood control valve to aid in the prevention of blood exposure each time the device is accessed.”
The Introcan Safety 3 features all elements of B Braun’s existing and proven Introcan Safety IV catheter. From insertion to advancing the catheter to needle removal, the Introcan Safety 3 is designed to help protect clinicians and patients from NSIs as the device cannot be bypassed or activated inadvertently.